Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer

Modern Pathology

Volumn 18, Issue 3, 2005, Pages 431-438

  Friedrichs, Nicolaus ^a   Jäger, Richard ^a   Paggen, Ellen ^a   Rudlowski, Christian ^b   Merkelbach Bruse, Sabine ^a   Schorle, Hubert ^a   Buettner, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

AP 2; Breast cancer; Immunohistochemistry; Transcription factor; Tumorigenesis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; TRANSCRIPTION FACTOR AP 2GAMMA; UNCLASSIFIED DRUG;

ARTICLE; BREAST; BREAST CANCER; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MYOEPITHELIUM CELL; PRIORITY JOURNAL; TISSUE MICROARRAY;

ACTINS; BREAST; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MUSCLE, SMOOTH; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SURVIVAL ANALYSIS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 15444361995     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800292     Document Type: Article

References (28)

1. Zhao F, Satoda M, Licht JD, et al. Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 2001;276: 40755-40760.
2. Feng W, Williams T. Cloning and characterization of the mouse AP-2epsilon gene: a novel family member expressed in the developing olfactory bulb. Mol Cell Neurosci 2003;24:460-475.
3. Hilger-Eversheim K, Moser M, Schorle H, et al. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 2000;260:1-12.
4. Williams T, Tjian R. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 1991;5:670-682.
5. Williams T, Tjian R. Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science 1991;251:1067-1071.
6. Turner BC, Zhang J, Gumbs AA, et al. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factors signalling pathways. Cancer Res 1998;58: 5466-5472.
7. Zhang J, Brewer S, Huang J, et al. Overexpression of transcription factor Ap-2 alpha suppresses mammary gland growth and morphogenesis. Dev Biol 2003; 256:127-145.
8. Schorle H, Meier P, Buchert M, et al. Transcription factor AP-2 esential for cranial closure and craniofacial development. Nature 1996;381:235-238.
9. Moser M, Pscherer A, Roth C, et al. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Genes Dev 1997; 11:1938-1948.
10. Zhang J, Hagopian-Donaldson S, Serbedzija G, et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 1996;381: 238-241.
11. Werling U, Schorle H. Transcription factor gene AP-2 gamma essential for early murine development. Mol Cell Biol 2002;22:3149-3156.
12. Jäger R, Werling U, Rimpf S, et al. Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model. Mol Cancer Res 2003;1:921-929.
13. Bosher JM, Williams T, Hurst HC. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 1995;92: 744-747.
14. Bosher JM, Totty NF, Hsuan JJ, et al. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 1996;13:1701-1707.
15. Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1994; 1198:165-184.
16. Williamson JA, Bosher JM, Skinner A, et al. Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics 1996;35:262-264.
17. McPherson LA, Baichwal VR, Weigel RJ. Identification of ERF-1 as a member of the AP-2 transcription factor family. Proc Natl Acad Sci USA 1997;94:4342-4347.
18. Pellikainen J, Kataja V, Ropponen K, et al. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Clin Cancer Res 2002;8:3487-3495.
19. Gee JM, Robertson JF, Ellis IO, et al. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol 1999;189:514-520.
20. Merkelbach-Bruse S, Wardelmann E, Behrens P, et al. Current diagnostic methods of HER-2/neu-detection in breast cancer with special regard to real-time PCR. Am J Surg Pathol 2003;27:1565-1570.
21. Bosserhoff AK, Moser M, Hein R, et al. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers. J Pathol 1999; 187:446-454.
22. Birner P, Oberhuber G, Stani J, et al. Evaluation of the United States Food and Drug Administration-approved Scoring and Test system of HER-2 Protein Expression in Breast Cancer. Clin Cancer Res 2001;7:1669-1675.
23. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987;8: 138-140.
24. Buettner R, Kannan P, Imhof A, et al. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol 1993;13:4174-4185.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
26. Henderson IC, Patek AJ. The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat 1998;52: 261-288.
27. Boecker W, Buerger H. Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif 2003; 36(Suppl 1):73-84.
28. Boecker W, Moll R, Dervan P, et al. Usual ductal hyperplasia of a breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol 2002; 198:458-467.